drugset / Trial / NCT03333603
Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients
Phase 4
Completed
25 enrolled
National Taiwan University Hospital
National Taiwan University · collab
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the pharmacokinetic and safety for the esomeprazole use for schizophrenia
Timeline
- Start
- 2016-05-23
- Primary completion
- 2017-01-23
- Completion
- 2017-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 80 mg | Oral |